Health Catalyst, Inc. (HCAT)
NASDAQ: HCAT · Real-Time Price · USD
7.09
+0.12 (1.72%)
Dec 20, 2024, 4:00 PM EST - Market closed
Health Catalyst Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Health Catalyst stock have an average target of 11.75, with a low estimate of 9.00 and a high estimate of 16. The average target predicts an increase of 65.73% from the current stock price of 7.09.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for HCAT stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 6 | 6 | 5 | 5 | 5 | 5 |
| Hold | 3 | 4 | 4 | 4 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 12 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Piper Sandler | Piper Sandler | Buy Reiterates $11 → $12 | Buy | Reiterates | $11 → $12 | +69.25% | Nov 26, 2024 |
| Stephens & Co. | Stephens & Co. | Hold Maintains $7 → $9 | Hold | Maintains | $7 → $9 | +26.94% | Nov 14, 2024 |
| Citigroup | Citigroup | Strong Buy Maintains $9 → $11 | Strong Buy | Maintains | $9 → $11 | +48.10% | Nov 13, 2024 |
| RBC Capital | RBC Capital | Hold Maintains $8 → $9 | Hold | Maintains | $8 → $9 | +26.94% | Nov 7, 2024 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $8 → $10 | Buy | Maintains | $8 → $10 | +41.04% | Oct 8, 2024 |
Financial Forecast
Revenue This Year
313.82M
from 295.94M
Increased by 6.04%
Revenue Next Year
348.95M
from 313.82M
Increased by 11.19%
EPS This Year
0.32
from -2.09
EPS Next Year
0.40
from 0.32
Increased by 27.29%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 324.5M | 364.4M | 411.9M |
| Avg | 313.8M | 349.0M | 388.8M |
| Low | 299.4M | 330.5M | 364.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 9.6% | 16.1% | 18.0% |
| Avg | 6.0% | 11.2% | 11.4% |
| Low | 1.2% | 5.3% | 4.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 0.41 | 0.60 | 0.95 |
| Avg | 0.32 | 0.40 | 0.58 |
| Low | 0.25 | 0.18 | 0.32 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | 89.7% | 137.3% |
| Avg | - | 27.3% | 44.4% |
| Low | - | -44.1% | -19.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.